Researchers found that treating acute ischemic stroke patients with t-PA can result in a substantial net cost savings due to shorter hospital stays and decreased long-term disabilities. This treatment also improves patient outcomes and quality of life.
A new study reveals that most people in the Cincinnati area can't identify even one symptom of stroke, despite being at high risk. The study found that those over 75 years old knew the least about stroke symptoms and risk factors, highlighting the need for more public education.
A large clinical trial found that widely used therapy with LMW heparinoids after a stroke has little effect on producing good outcomes or preventing second strokes. However, the therapy may be beneficial for patients with large artery atherosclerosis.
A new study found that low-risk atrial fibrillation patients who take aspirin have a lower risk of stroke compared to those on warfarin, with fewer bleeding complications. The study identified hundreds of thousands of Americans eligible for aspirin therapy and provides new insights into stroke prevention.
Scientists have identified peptides substance P and neurokinin A as key components in the body's pain responses. The study suggests that these peptides work together to produce moderate-to-severe pain, offering a potential target for new pain treatments.
A new study recalculates stroke incidence in the US, estimating approximately 731,100 first and recurrent strokes annually. The study found a 200,000-stroke increase over previous estimates, with higher rates among African Americans.
Researchers have shown that TMS can modify brain reorganization, potentially accelerating recovery and rehabilitation. The technique may also be used to promote learning and improve brain function after injuries or trauma.
Scientists at NIH developed a new drug that reduces tumor size without severe side effects. In a clinical trial, 9 of 15 patients had significant tumor regression, with complete disappearance in two cases. A related therapy using virus-producing cells also showed promise, but only for small tumors.
A study by the National Institute of Neurological Disorders and Stroke found that more than 70% of MS patients exhibited an increased immune response to human herpes virus-6, suggesting a potential trigger for the disease. Active HHV-6 was detected in approximately 35% of all MS patients studied.
Researchers have identified a genetic susceptibility locus for ET, a debilitating disorder characterized by tremors in the arms, head, neck, and voice. The discovery paves the way for future research to identify the cause of ET and develop more effective treatments.
Researchers have identified a gene responsible for late infantile Batten disease, a devastating genetic disorder that affects about 300 children in the US. The CLN2 gene codes for an enzyme that degrades proteins and its discovery may lead to effective treatment and new insights into the aging process.
Researchers have discovered a new class of proteins that may provide insights into all dystonia disorders. The DYT1 gene codes for torsinA protein, which is mutated in patients with early-onset torsion dystonia, disrupting communication among neurons responsible for movement and muscle control.
Researchers have identified the TSC2 gene as the second gene responsible for tuberous sclerosis complex (TSC), a genetic disorder affecting 1 million people worldwide. The discovery of this gene brings hope for diagnostic testing, therapies, and improved understanding of autism and seizure disorders.
Researchers found a yeast protein similar to frataxin controls iron levels in mitochondria, leading to cell death and oxidative damage. The study suggests iron overload may be a key factor in Friedreich's ataxia, but further research is needed for treatment.
A new study shows that giving the drug for a longer period can significantly improve recovery over the standard treatment. About 60% of patients treated with 48-hour methylprednisolone starting at three to eight hours recovered a substantial degree of independence.